Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.
3.

Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.

Wakeling AE, Valcaccia B.

J Endocrinol. 1983 Dec;99(3):455-64.

PMID:
6644236
4.

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.

Jordan VC, Collins MM, Rowsby L, Prestwich G.

J Endocrinol. 1977 Nov;75(2):305-16.

PMID:
591813
5.

Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.

Nishino Y, Schneider MR, Michna H, von Angerer E.

J Endocrinol. 1991 Sep;130(3):409-14.

PMID:
1834757
7.

Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.

Wakeling AE, O'Connor KM, Newboult E.

J Endocrinol. 1983 Dec;99(3):447-53.

PMID:
6644235
8.

Novel antioestrogens without partial agonist activity.

Wakeling AE, Bowler J.

J Steroid Biochem. 1988 Oct;31(4B):645-53.

PMID:
3199810
10.

[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].

Borgna JL.

Bull Cancer. 1994 Jan;81(1):29-37. Review. French.

PMID:
7949581
11.
12.

Interaction of spironolactone with oestradiol receptors in cytosol.

Levy J, Burshell A, Marbach M, Afllalo L, Glick SM.

J Endocrinol. 1980 Mar;84(3):371-9.

PMID:
7391714
15.
16.

Steroidal pure antioestrogens.

Wakeling AE, Bowler J.

J Endocrinol. 1987 Mar;112(3):R7-10.

PMID:
3559447
17.
18.

Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.

Chwalisz K, Stöckemann K, Fritzemeier KH, Fuhrmann U.

Hum Reprod Update. 1998 Sep-Oct;4(5):570-83.

20.

Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens.

Branham WS, Zehr DR, Sheehan DM.

Proc Soc Exp Biol Med. 1993 Jul;203(3):297-303.

PMID:
8516342
Items per page

Supplemental Content

Write to the Help Desk